However, in prostate cancer, MEIS2 shows a negative role in the regulation of the constitutive intrinsic inflammatory signaling circuit that promotes the development castration‐resistant prostate cancer (CRPC).12, 16, 17. This evidence concerns the gene MEIS2 and prostate carcinoma.